首页> 外国专利> USE OF POLYCLY 2-AMINOTIAZOL SYSTEMS FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF LIPOMETABOLIC DISORDERS, OBESITY AND TYPE II DIABETES.

USE OF POLYCLY 2-AMINOTIAZOL SYSTEMS FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF LIPOMETABOLIC DISORDERS, OBESITY AND TYPE II DIABETES.

机译:聚合物2-氨基噻唑系统在制造治疗脂代谢紊乱,肥胖症和II型糖尿病的药物中的应用。

摘要

Use of compounds of formula I, ** (Formula) ** in which Y means a direct bond; X means CH2; R1 means CF3, CN, COOH, COO (C1-C6 alkyl), CONH2, CONH (C1-C6 alkyl), CON (C1-C6 alkyl) 2, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, O- (C1-C6 alkyl), one, several or all hydrogens of the alkyl, alkenyl and alkynyl radicals being replaced by fluorine; SO2-NH2, SO2NH (C1-C6 alkyl), SO2N (C1-C6 alkyl) 2, S- (C1-C6 alkyl), S- (CH2) n-phenyl, SO- (C1-C6 alkyl), SO- (CH2) n-phenyl, SO2- (C1-C6 alkyl), SO2- (CH2) n-phenyl, which may be n = 0-6, and the phenyl radical may be substituted up to twice with F, Cl, Br, OH, CF3, NO2, CN, OCF3, O- (C1-C6 alkyl), C1-C6 alkyl, NH2; phenyl, O-phenyl, the phenyl radical may be substituted up to three times with F, Cl, Br, I, OH, CF3, NO2, CN, OCF3, O- (C1-C6 alkyl), C1-C6 alkyl, NH2, NH (C1-C6 alkyl), N (C1-C6 alkyl) 2, SO2-CH3, COOH, COO- (C1-C6 alkyl), CONH2; Does R1 mean H, CF3, CN, COOH, COO (C1-C6 alkyl), CONH2, CONH (C1-C6 alkyl), CON (C1-C6 alkyl) 2, C1-C6 alkyl, C2-C6 alkenyl, C2 alkynyl -C6, O- (C1-C6 alkyl), one, several or all hydrogens of the alkyl, alkenyl and alkynyl radicals being replaced by fluorine; SO2-NH2, SO2NH (C1-C6 alkyl), SO2N (C1-C6 alkyl) 2, S- (C1-C6 alkyl), S- (CH2) n-phenyl, SO- (C1-C6 alkyl), SO- (CH2) n-phenyl, SO2- (C1-C6 alkyl), SO2- (CH2) n-phenyl, which may be n = 0-6, and the phenyl radical may be substituted up to twice with F, Cl, Br, OH, CF3, NO2, CN, OCF3, O- (C1-C6 alkyl), C1-C6 alkyl, NH2; phenyl, O-phenyl, the phenyl radical may be substituted up to three times with F, Cl, Br, I, OH, CF3, NO2, CN, OCF3, O- (C1-C6 alkyl), C1-C6 alkyl, NH2, NH (C1-C6 alkyl), N (C1-C6 alkyl) 2, SO2-CH3, COOH, COO- (C1-C6 alkyl), CONH2; R2 means NH2, NHR3, NR4R5; R3 means C1-C6 alkyl; R4 means C1-C6 alkyl; R5 means C1-C6 alkyl; and its physiologically acceptable salts, to prepare a medicament for treating metabolism disorders.
机译:式I,**(式)**化合物的用途,其中Y表示直接键; X表示CH 2; R1是指CF3,CN,COOH,COO(C1-C6烷基),CONH2,CONH(C1-C6烷基),CON(C1-C6烷基)2,C1-C6烷基,C2-C6烯基,C2-C6炔基, O-(C1-C6烷基),烷基,烯基和炔基的一个,几个或全部氢被氟取代; SO2-NH2,SO2NH(C1-C6烷基),SO2N(C1-C6烷基)2,S-(C1-C6烷基),S-(CH2)正苯基,SO-(C1-C6烷基),SO- (CH 2)正苯基,SO 2-(C 1 -C 6烷基),SO 2-(CH 2)正苯基,其可以为n = 0-6,并且苯基可以被F,Cl,Br最多取代两次。 ,OH,CF 3,NO 2,CN,OCF 3,O-(C 1 -C 6烷基),C 1 -C 6烷基,NH 2;苯基,O-苯基,苯基可被F,Cl,Br,I,OH,CF3,NO2,CN,OCF3,O-(C1-C6烷基),C1-C6烷基,NH2取代多达3次,NH(C 1 -C 6烷基),N(C 1 -C 6烷基)2,SO 2 -CH 3,COOH,COO-(C 1 -C 6烷基),CONH 2; R1是否表示H,CF3,CN,COOH,COO(C1-C6烷基),CONH2,CONH(C1-C6烷基),CON(C1-C6烷基)2,C1-C6烷基,C2-C6烯基,C2炔基-C6,O-(C1-C6烷基),烷基,烯基和炔基的一个,几个或全部氢被氟取代; SO2-NH2,SO2NH(C1-C6烷基),SO2N(C1-C6烷基)2,S-(C1-C6烷基),S-(CH2)正苯基,SO-(C1-C6烷基),SO- (CH 2)正苯基,SO 2-(C 1 -C 6烷基),SO 2-(CH 2)正苯基,其可以为n = 0-6,并且苯基可以被F,Cl,Br最多取代两次。 ,OH,CF 3,NO 2,CN,OCF 3,O-(C 1 -C 6烷基),C 1 -C 6烷基,NH 2;苯基,O-苯基,苯基可被F,Cl,Br,I,OH,CF3,NO2,CN,OCF3,O-(C1-C6烷基),C1-C6烷基,NH2取代多达3次,NH(C 1 -C 6烷基),N(C 1 -C 6烷基)2,SO 2 -CH 3,COOH,COO-(C 1 -C 6烷基),CONH 2; R2是指NH2,NHR3,NR4R5; R3是指C1-C6烷基; R4是指C1-C6烷基; R5是指C1-C6烷基;及其生理上可接受的盐,以制备治疗代谢紊乱的药物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号